Clinicare Speciality Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.47 M
- Revenue Growth 45.05%
- Profit Growth 110.87%
- Ebitda 47.38%
- Net Worth 3.31%
- Total Assets 101.21%
About Clinicare Speciality Laboratories
Clinicare Speciality Laboratories Private Limited (CSLPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 September 2014 and has a history of Ten years and four months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.47 M.
Vedant Rathi and Rajkumar Rathi serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74120MH2014PTC258139
- Company No.
258139
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Clinicare Speciality Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vedant Rathi  | Director | 16-Sep-2014 | Current |
| Rajkumar Rathi | Director | 16-Sep-2014 | Current |
Financial Performance of Clinicare Speciality Laboratories.
Clinicare Speciality Laboratories Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 45.05% increase. The company also saw a substantial improvement in profitability, with a 110.87% increase in profit. The company's net worth moved up by a moderate rise of 3.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clinicare Speciality Laboratories?
In 2020, Clinicare Speciality Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.47 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Nov 2019 | Others | ₹1.47 M | Open |
How Many Employees Work at Clinicare Speciality Laboratories?
Unlock and access historical data on people associated with Clinicare Speciality Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinicare Speciality Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinicare Speciality Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.